The CBD Nutraceuticals Market 🌿, valued at USD 3.8 Billion in 2022, is projected to reach USD 16.9 Billion by 2032 with a Compound Annual Growth Rate (CAGR) of 16.3% 💼. CBD, derived from the cannabis sativa plant, is renowned for its medicinal properties, treating conditions like epilepsy, pain, and Parkinson's disease. Unlike THC, hashtag#CBD is non-psychoactive and is increasingly integrated into nutraceuticals for its health benefits. Rising awareness of CBD's potential health advantages, coupled with the growing focus on maintaining healthy lifestyles, fuels market growth 📈. Notably, CBD products are popular for alleviating anxiety, improving sleep, and reducing stress, with over half of respondents in a Forbes Health Survey reporting CBD use for these purposes. 🌱

Posted by ICBC - InternationalCBC at 2024-02-22 01:22:51 UTC